DeSilva, Mary http://orcid.org/0000-0001-6367-1870
Vu, Cong Nguyen
Bonawitz, Rachael
Hai, Le Thanh
Van Lam, Nguyen
Yen, Le Thi
Gifford, Allen L.
Haberer, Jessica
Linh, Dang Thuy
Sabin, Lora
Funding for this research was provided by:
National Institute of Mental Health (R21 MH109381-01)
Article History
Received: 15 August 2017
Accepted: 31 January 2019
First Online: 28 February 2019
Ethics approval and consent to participate
: The study was approved by the Institutional Review Boards of the University of New England (reference 071316–001), the Institute for Population Health and Development (reference PHAD-2016/SAAV-01), and the Ethics Committee of the National Hospital for Pediatrics in Hanoi (reference VNCH-RICH-16-015). Any protocol modifications will be submitted to the IRB for review and participants will be informed if warranted. After eligibility screening, we will request signed consent from caregivers before seeking assent from their adolescent children. Clinician participants in the FGD will also be requested to provide consent. The study coordinator will administer the consent process in all cases. For the RCT, consent and assent will be reviewed at each study visit so that participants have an opportunity to stop participation if they desire.
: Not applicable.
: JH has been a consultant for Merck and owns stock in Natera. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.